Whole-Body PET/MRI Applications in Pediatric Oncology.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32755171.
- Also identified by DOI 10.2214/AJR.19.22677.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> Fluorine-18-labeled FDG PET/CT and MRI are current imaging standards for staging and assessing tumor response and recurrence of pediatric extracranial solid tumors. PET/MRI combines anatomic and physiologic imaging in a single session with reduced radiation compared with CT. Pediatric protocols are primarily whole-body protocols because of the behavior and type of cancers unique to children. This article will focus on the practice and utility of whole-body PET/MRI for pediatric oncologic imaging. <b>CONCLUSION.</b> The strengths of PET/MRI over PET/CT are compelling and include decreased radiation exposure, decreased number of sedation and general anesthesia events, single-day one-stop visits, and simultaneous imaging with two stand-alone advanced imaging techniques essential to staging and assessing treatment response in pediatric oncology.
Medical subject headings
- Magnetic Resonance Imaging
- Multimodal Imaging
- Neoplasms
- Pediatrics
- Positron-Emission Tomography
- Whole Body Imaging